Scilex Holding Co (SCLX)
0.9054
+0.04
(+4.07%)
USD |
NASDAQ |
May 17, 16:00
0.938
+0.03
(+3.60%)
After-Hours: 20:00
Scilex Total Assets (Quarterly): 91.24M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 91.24M |
| December 31, 2023 | 101.31M |
| September 30, 2023 | 80.53M |
| June 30, 2023 | 126.46M |
| Date | Value |
|---|---|
| March 31, 2023 | 86.05M |
| December 31, 2022 | 86.53M |
| September 30, 2022 | 88.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
80.53M
Minimum
Sep 2023
126.46M
Maximum
Jun 2023
94.41M
Average
88.78M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | 456.69M |
| Adial Pharmaceuticals Inc | 4.737M |
| Precision BioSciences Inc | 184.74M |
| Humacyte Inc | 161.47M |
| Perspective Therapeutics Inc | 278.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 281.03M |
| Shareholders Equity (Quarterly) | -189.79M |
| Debt to Equity Ratio | -0.5756 |
| Current Ratio | 0.1493 |
| Net Debt Paydown Yield | -12.95% |